John Wilson

John Wilson is the Founder and CEO of Wilson Wolf Manufacturing Corporation, a company focused on simplifying cell and gene therapy manufacturing. John also founded CellReady, a company aimed at accelerating the path to meaningful clinical data for cell and gene therapy companies. John is a Co-Founder and Board Member of Wilson Foundation Minnesota, which supports impactful organizations and programs. John is also a Co-Founder and Board of Director Member of ScaleReady, a joint venture dedicated to revolutionizing cell and gene therapy manufacturing. Previously, John was the Co-Founder, CEO, and Director of Marker Therapeutics, where they developed a manufacturing platform for T cell therapies. John also co-founded AlloVir, a public company that commercializes virus-specific T cell therapies.

John Wilson has a degree in Mechanical Engineering BS from the University of Minnesota. John also holds a Business Administration BA and an Economics BA from Hamline University. The specific start and end years for each degree are not provided.